842 related articles for article (PubMed ID: 26232154)
1. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice.
Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN
J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154
[TBL] [Abstract][Full Text] [Related]
2. Microglia depletion rapidly and reversibly alters amyloid pathology by modification of plaque compaction and morphologies.
Casali BT; MacPherson KP; Reed-Geaghan EG; Landreth GE
Neurobiol Dis; 2020 Aug; 142():104956. PubMed ID: 32479996
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology.
Olmos-Alonso A; Schetters ST; Sri S; Askew K; Mancuso R; Vargas-Caballero M; Holscher C; Perry VH; Gomez-Nicola D
Brain; 2016 Mar; 139(Pt 3):891-907. PubMed ID: 26747862
[TBL] [Abstract][Full Text] [Related]
4. Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease.
Sosna J; Philipp S; Albay R; Reyes-Ruiz JM; Baglietto-Vargas D; LaFerla FM; Glabe CG
Mol Neurodegener; 2018 Mar; 13(1):11. PubMed ID: 29490706
[TBL] [Abstract][Full Text] [Related]
5. Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model.
Spangenberg E; Severson PL; Hohsfield LA; Crapser J; Zhang J; Burton EA; Zhang Y; Spevak W; Lin J; Phan NY; Habets G; Rymar A; Tsang G; Walters J; Nespi M; Singh P; Broome S; Ibrahim P; Zhang C; Bollag G; West BL; Green KN
Nat Commun; 2019 Aug; 10(1):3758. PubMed ID: 31434879
[TBL] [Abstract][Full Text] [Related]
6. Microglial Depletion with CSF1R Inhibitor During Chronic Phase of Experimental Traumatic Brain Injury Reduces Neurodegeneration and Neurological Deficits.
Henry RJ; Ritzel RM; Barrett JP; Doran SJ; Jiao Y; Leach JB; Szeto GL; Wu J; Stoica BA; Faden AI; Loane DJ
J Neurosci; 2020 Apr; 40(14):2960-2974. PubMed ID: 32094203
[TBL] [Abstract][Full Text] [Related]
7. Microglial response to Alzheimer's disease is differentially modulated by voluntary wheel running and enriched environments.
Rodríguez JJ; Noristani HN; Verkhratsky A
Brain Struct Funct; 2015 Mar; 220(2):941-53. PubMed ID: 24374506
[TBL] [Abstract][Full Text] [Related]
8. CSF1R inhibition rescues tau pathology and neurodegeneration in an A/T/N model with combined AD pathologies, while preserving plaque associated microglia.
Lodder C; Scheyltjens I; Stancu IC; Botella Lucena P; Gutiérrez de Ravé M; Vanherle S; Vanmierlo T; Cremers N; Vanrusselt H; Brône B; Hanseeuw B; Octave JN; Bottelbergs A; Movahedi K; Dewachter I
Acta Neuropathol Commun; 2021 Jun; 9(1):108. PubMed ID: 34103079
[TBL] [Abstract][Full Text] [Related]
9. Concentration-dependent effects of CSF1R inhibitors on oligodendrocyte progenitor cells ex vivo and in vivo.
Liu Y; Given KS; Dickson EL; Owens GP; Macklin WB; Bennett JL
Exp Neurol; 2019 Aug; 318():32-41. PubMed ID: 31029597
[TBL] [Abstract][Full Text] [Related]
10. Elimination of microglia improves cognitive function following cranial irradiation.
Acharya MM; Green KN; Allen BD; Najafi AR; Syage A; Minasyan H; Le MT; Kawashita T; Giedzinski E; Parihar VK; West BL; Baulch JE; Limoli CL
Sci Rep; 2016 Aug; 6():31545. PubMed ID: 27516055
[TBL] [Abstract][Full Text] [Related]
11. Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology.
Spangenberg EE; Lee RJ; Najafi AR; Rice RA; Elmore MR; Blurton-Jones M; West BL; Green KN
Brain; 2016 Apr; 139(Pt 4):1265-81. PubMed ID: 26921617
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting and modulation of plaque associated microglia via systemic hydroxyl dendrimer administration in an Alzheimer's disease mouse model.
Henningfield CM; Soni N; Lee RW; Sharma R; Cleland JL; Green KN
Alzheimers Res Ther; 2024 May; 16(1):101. PubMed ID: 38711159
[TBL] [Abstract][Full Text] [Related]
13. Increased densities of resting and activated microglia in the dentate gyrus follow senile plaque formation in the CA1 subfield of the hippocampus in the triple transgenic model of Alzheimer's disease.
Rodríguez JJ; Noristani HN; Hilditch T; Olabarria M; Yeh CY; Witton J; Verkhratsky A
Neurosci Lett; 2013 Sep; 552():129-34. PubMed ID: 23827221
[TBL] [Abstract][Full Text] [Related]
14. Microglia facilitate loss of perineuronal nets in the Alzheimer's disease brain.
Crapser JD; Spangenberg EE; Barahona RA; Arreola MA; Hohsfield LA; Green KN
EBioMedicine; 2020 Aug; 58():102919. PubMed ID: 32745992
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.
Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW
Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657
[TBL] [Abstract][Full Text] [Related]
16. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
[TBL] [Abstract][Full Text] [Related]
17. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice.
Unger MS; Schernthaner P; Marschallinger J; Mrowetz H; Aigner L
J Neuroinflammation; 2018 Sep; 15(1):274. PubMed ID: 30241479
[TBL] [Abstract][Full Text] [Related]
18. Nobiletin, a citrus flavonoid, improves cognitive impairment and reduces soluble Aβ levels in a triple transgenic mouse model of Alzheimer's disease (3XTg-AD).
Nakajima A; Aoyama Y; Shin EJ; Nam Y; Kim HC; Nagai T; Yokosuka A; Mimaki Y; Yokoi T; Ohizumi Y; Yamada K
Behav Brain Res; 2015 Aug; 289():69-77. PubMed ID: 25913833
[TBL] [Abstract][Full Text] [Related]
19. Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice.
Jagadeesan N; Roules GC; Chandrashekar DV; Yang J; Kolluru S; Sumbria RK
J Transl Med; 2024 Mar; 22(1):291. PubMed ID: 38500108
[TBL] [Abstract][Full Text] [Related]
20. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
Boissonneault V; Filali M; Lessard M; Relton J; Wong G; Rivest S
Brain; 2009 Apr; 132(Pt 4):1078-92. PubMed ID: 19151372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
